Background: Blood is a life saving resource but at the same times however, blood transfusion can be a source of life threatening infections, if screening is not carried out properly [1] .
Introduction
Blood is a life saving resource but at the same times however, blood transfusion can be a source of life threatening infections, if screening is not carried out properly [1] . It is also the most efficient vehicle for the transmission of human immunodeficiency virus (HIV). Hence there is a need for accurate screening of HIV among blood donors. As per National Acquired immunodeficiency syndrome Control Organisation (NACO), the prevalence of human immunodeficiency virus (HIV) infection in adults in India is 0.27% [2] . There are many reports about the HIV prevalence among blood donors in India, the rate ranging between 0.084% to 3.87% [3] [4] [5] [6] [7] [8] [9] . Blood transfusion is an integral and life saving procedure of modern medicine, but simultaneously it carries the risk of transmitting the life-threatening transfusion-transmissible infectious agents such as human immunodeficiency virus (HIV). Thus ensuring the safety of blood is a major concern in transfusion therapy although the improved screening and testing of blood donors has significantly reduced transfusiontransmitted diseases. In 1982, the Morbidity and Mortality Weekly Report from the Centres for Disease Control (CDC) provided information on possible transmission of acquired immunodeficiency syndrome (AIDS) by contaminated blood and blood product (Centre for Disease Control: Update on acquired immunodeficiency syndrome (AIDS) among patients with haemophilia A. MMWR. 1982; 31:644-51) Since then, public and private health institutions, blood banks and manufacturers of diagnostic tests have collaborated to develop a blood safety vigilance system to reduce transfusion-related human immunodeficiency virus (HIV) transmission. In 1985, the first specific HIV type 1 (HIV-1) antibody test was licensed and blood donors then underwent double screening: a) an extensive pre-donation questionnaire to determine donor eligibility and b) post-donation HIV-1 antibody testing. The most commonly used method for detecting HIV antibodies (HIV Ab) has been enzymelinked immunosorbent assay (ELISA). The performance of HIV screening assays has improved substantially over the years.
~ 23 ~ Material and methods 500 random blood donors of Vadilal Sarabhai Hospital were evaluated.
Selection of patients Inclusion criteria:
Total sample number included the number of blood donors donating blood only once during study period.
Exclusion criteria: Repeated donation of same donor during study period will be excluded & known seropositive donor for any infectious disease are excluded Type of study: Cross sectional study
Samples & sampling technique
Serum Samples of blood donors are studied.
Total 500 donors are studied. Prior to blood donation, donors were requested to answer the questionnaire to determine whether they were eligible for donation as per the criteria set by "NACO". Both the first time donors & repeated donors will be included in the study. 2 milliliters of each donor's blood are dispensed in a plain vacuatte labeled with sample number for mandatory screening for Transfusion Transmitted infections. Serum samples were tested for HIV by rapid, 3 rd generation Elisa & 4 th generation Elisa.
Results
All serum sample of 500 random donors are tested with rapid method, 3rd and 4th generation ELISA for diagnosis of H.I.V. Standard Operative Procedures are following in each test. 
Discussion
Detection of HIV infections and diagnosis is mainly based on immunological assays among which ELISA and rapid tests are most common and widespread methods [10] [11] [12] . An important problem encountered at this point is the discordance between the results of two assays [13] . Which can be resolved depending on the availability of suitable kits. Hence, kit evaluation gains importance for determining the diagnostic kits of better performance. Though ELISA assay shows a high degree of sensitivity, it is costly and time taking, so rapid tests become a good alternative for ELISA in blood banks. Moreover, uses of synthetic antigens in some rapid kits have increased the specificity [virology 25]. Performance of rapid test is also satisfactory.
According VP torane et al. study in Mumbai rapid diagnostic kits are inferior compared to ELISA. So rapid kits are not be recommended at transfusion centre or blood bank for screening. According to rajesh kannangai et al study they found rapid kits as satisfactory as ELISA in screening 7 other study as in our study. According to harjeet kaur et al they found rapid kit is 100% specific for HIV detection but less sensitivity. So They haven't shown any promising results in their study. The rapid tests have advantages such as ease of use, minimal training required for the user, easy interpretation, and a long shelf life. These tests can be done with a short turnaround time, avoiding the delay incurred in batching. Thus, rapid tests can be used as an alternative to ELISAs in blood banks. The disadvantages of the enzyme-linked immunosorbent assay (ELISA) are the need for well-trained technical manpower, appropriate equipment, and batch testing. In a developing country such as India, technical support is not available in most of the blood banks.
